Chargement en cours...
Utility of obesity and metabolic dyslipidemia (a non‐insulin based determinate of the metabolic syndrome and insulin resistance) in predicting arterial stiffness
Increased arterial stiffening is not only a hallmark of the aging process but the consequence of many metabolic abnormalities such as insulin resistance (IR), obesity, and metabolic dyslipidemia. In patients with the cardiometabolic syndrome, arterial stiffening is consistently observed across all a...
Enregistré dans:
| Publié dans: | J Clin Hypertens (Greenwich) |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6690773/ https://ncbi.nlm.nih.gov/pubmed/31318126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.13615 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|